Elevated Risk of Adverse Prognosis in Patients with T2-3 Stage Breast Cancer Exhibiting Non-Pathological Complete Response Following Neoadjuvant Chemotherapy: Significance of Regenerating Islet-Derived Family Member 4
Reg IV may serve as an independent risk factor and predictive marker for adverse outcomes in patients with T2-3 stage breast cancer who do not achieve non-pCR following NACT.
Authors
- Li Fan (ORCID: https://orcid.org/0000-0003-4722-3933)
- Jiawen Lin (ORCID: https://orcid.org/0000-0003-2950-1776)
- Shuqin Li (ORCID: https://orcid.org/0000-0002-7922-903X)
- Jun Shen (ORCID: https://orcid.org/0000-0002-8384-3526)
- Chuan-Guo Chen
- Jiao-Fei Wei
- Zi-ang Dou
Institutions
- The First People’s Hospital of Lianyungang (CN)
- Anshan Hospital (CN)
- Nanjing Medical University (CN)
- Jinzhou Medical University (CN)
Publication Details
- Journal
- Breast Cancer Targets and Therapy
- Published
- 2024-09-01
- DOI
- https://doi.org/10.2147/bctt.s473920
- Citations
- 1
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.29